Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| MindRhythm | 2021 | Seed | $5.0M | Cupertino |
| Stemson Therapeutics | 2021 | Series A | $15.0M | San Diego |
| Cape Analytics | 2021 | Series C | $44.0M | Palo Alto |
| Nylas | 2021 | Series C | $120.0M | San Francisco |
| Paperspace | 2021 | Series Unknown | $12.0M | New York |
| InnaMed | 2021 | Series Unknown | Undisclosed | Philadelphia |
| BioPhero | 2021 | Series A | $16.8M | Lyngby |
| Auransa | 2020 | Series A | $15.7M | Palo Alto |
| Pachyderm | 2020 | Series B | $16.0M | San Francisco |
| Virtual Power Systems | 2020 | Series Unknown | $12.0M | Milpitas |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 151 | MindRhythm | Seed | $5.0M | Cupertino, United States |
| 152 | Stemson Therapeutics | Series A | $15.0M | San Diego, United States |
| 153 | Cape Analytics | Series C | $44.0M | Palo Alto, United States |
| 154 | Nylas | Series C | $120.0M | San Francisco, United States |
| 155 | Paperspace | Series Unknown | $12.0M | New York, United States |
| 156 | InnaMed | Series Unknown | Undisclosed | Philadelphia, United States |
| 157 | BioPhero | Series A | $16.8M | Lyngby, Denmark |
| 158 | Auransa | Series A | $15.7M | Palo Alto, United States |
| 159 | Pachyderm | Series B | $16.0M | San Francisco, United States |
| 160 | Virtual Power Systems | Series Unknown | $12.0M | Milpitas, United States |
MindRhythm is an evolved neurodiagnostics company discovering and developing unique biometrics to solve unmet needs in medicine.
Stemson Therapeutics is a pre-clinical stage cell therapy company.
Cape Analytics provides AI and analytics services for properties.
Nylas is the cpaas company that empowers businesses worldwide to unlock the power of their communications data.
Paperspace powers next-generation applications built on GPUs.
InnaMed is a developer of a diagnostic device intended to provide early detection of illness.
BioPhero is a pioneer in providing low-cost bio-based pheromones for pest management.
A clinical stage drug development company who aims to invent novel drugs for hard-to-treat diseases using its proprietary AI platform
Pachyderm is an enterprise-grade data science platform that makes explainable, repeatable, and scalable AI/ML a reality.
Virtual Power Systems provides an Intelligent Control of Energy (ICE) platform that unlocks stranded power capacity in data centers.
Qumulo provides a file data platform for multi-cloud environments with large scale file data.
Caption Health is a medical company that uses artificial intelligence (AI) to interpret ultrasound exams.
Area 1 Security is a performance-based cybersecurity company, changing how businesses protect against phishing attacks.
BrainSpec is a health-tech company that enables accurate, efficient, and non-invasive diagnosis of brain disorders.
X-37 is a pharmaceutical discovery and development company
Descartes Labs is a technology company that automates the analysis of geospatial data to help organizations answer key questions.
Vicarious is an artificial intelligence firm that uses the computational principles of the brain to develop general intelligence.
Space Monkey provides a subscription-based data storage solution enabling users to store data from any device.
Bitfusion.io specializes in unlocking hardware acceleration without requiring application rewrite.
Elastic builds software to make data usable in real time and at scale for search, logging, security, and analytics use cases.
ApolloShield develops the active, plug & play anti-drone system.
Mirror uses a single selfie to instantly create hundreds of emoji that look like you and your friends.
SigOpt’s API tunes the model’s parameters through state-of-the-art Bayesian optimization.
Macromoltek does computational drug discovery for pharma companies, focusing on antibodies for therapeutics and diagnostics.
Enzyme is building software to help life sciences companies with FDA approval and regulatory compliance.
DCVC has invested in 212 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
DCVC's top investment sectors include Artificial Intelligence (AI), Software, Machine Learning, SaaS, Health Care. The firm invests across 54 different industry categories.
Among tracked funding rounds, Qumulo received $125.0M in a Series E round. DCVC's total known invested capital is $3.2B.
DCVC's average investment size is $25.7M across its portfolio of 212 companies.
Recent DCVC portfolio additions include MindRhythm, Stemson Therapeutics, Cape Analytics, Nylas, Paperspace. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors